REFERENCES
S. M. Kupchan, M. Maruyama, R. J. Hemingway, et al., J. Am. Chem. Soc., 93(19), 4914–4916 (1971).
K. Zh. Musulmanbekov, Proceedings of the Int. Sci.-Pract. Conf. “Clinical Use of the Antitumor Drug Arglabin” [in Russian], Karaganda (2002), pp. 46–51.
K. D. Rakhimov, Pharmacological Characterization of Natural Substances of Kazakhstan [in Russian], Almaty (1999), pp. 43–64.
T. E. Shaikenov, Proceedings of the Int. Sci.-Pract. Conf. “Clinical Use of the Antitumor Drug Arglabin” [in Russian], Karaganda (2002), pp. 57–67.
I. V. Anikin, G. V. Kukushkina, I. S. Sokolova, et al., Izv. Akad. Nauk SSSR, Ser. Biol., No. 2, 291–295 (1981).
A. S. Spirin, Biokhimiya, 23(5), 656–660 (1958).
S. V. Vasil’eva, A. M. Serebryanyi, and I. A. Rapoport, Genetika, 9(7), 80–84 (1973).
L. Grossman and A. T. Yeung, Photochem. Photobiol., 51(6), 749–755 (1990).
S. Chwalinski and C. S. Potten, Cell Tissue Kinet., 19(6), 647–659 (1986).
L. Thelander and P. Reichard, Ann. Rev. Biochem., 48, 133–158 (1979).
Author information
Authors and Affiliations
Additional information
__________
Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 38, No. 12, pp. 8 – 10, December, 2004.
Rights and permissions
About this article
Cite this article
Zhangabylov, N.S., Dederer, L.Y., Gorbacheva, L.B. et al. Sesquiterpene lactone arglabin influences DNA synthesis in P388 leukemia cells in vivo . Pharm Chem J 38, 651–653 (2004). https://doi.org/10.1007/s11094-005-0052-9
Received:
Issue Date:
DOI: https://doi.org/10.1007/s11094-005-0052-9